Resideo Technologies, Inc.

Scottsdale, AZ Wholesale tradeNAICS 423600

Self-funded health planPlan year 2025Renews JanuaryCollectively bargained
4,151Participants+22% vs. prior year
$9.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#2 of 7Wholesale trade in AZBy participants

Overview

Resideo Technologies, Inc. sponsors a self-funded health plan that covered 4,151 participants in plan year 2025, up 22% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
4,151 · prior year 3,416
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Resideo Technologies, Inc. Health and Welfare Benefit Plan, plan 501 (4,151 participants)
Stop-loss carrier
Cigna Health and Life Insurance Company
Broker compensation
$720K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Cigna Health and Life Insurance CompanyDental, HMO, Stop-loss6,630$6.1M$451K
Securian Life Insurance CompanyLife, Voluntary AD&D4,231$2.2M$140K
Life Insurance Company of North AmericaLong-term disability, Short-term disability, Family Medical Leave4,460$1.0M$49K
Kaiser Foundation Health Plan, Inc.Medical106$986K$51K
Vision Service PlanVision2,776$452K$24K
New York Life Group Insurance Company of New YorkShort-term disability180$192K$2K
National Union Fire Ins. Co. of PittsburghAD&D4,231$12K$2K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$9.8M/ year

Estimated prescription spend: 4,151 participants × $2,371 national average per member. Usually higher once dependents are counted.

$256K–$631K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$75K–$187K
Lower-cost therapeutic alternatives$109K–$228K
Generic pricing vs. actual cost$47K–$142K
PBM contract terms$25K–$74K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Resideo Technologies, Inc.
Sponsor EIN
82-5318796
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 82-5318796 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Resideo Technologies, Inc. 401(k) Plan
Type
401(k) plan
Participants
5,159

About this data

Source: Resideo Technologies, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Resideo Technologies, Inc..

Request a correction · Methodology